Rob Hegele welcomes the upsurge in interest in triglycerides – the ‘neglected cousins’ of the lipid world – and looks forward to learning more about latest concepts and contributing his own clinical and research experience to the Triglyceride Forum.
Derick Raal describes the need for the Triglyceride Forum at a time when triglycerides are increasingly recognised as an important target for reducing residual cardiovascular risk after conventional lipid lowering therapy, as well as risk of pancreatitis.
Chris Packard explains that, as research points to the contributory role of triglyceride-rich lipoproteins in the atherogenic process, the Triglyceride Forum will be of interest to lipidologists, cardiologists, endocrinologists and many others involved in internal medicine.
